251 related articles for article (PubMed ID: 32123491)
1. Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring.
Esmeray E; Küçük C
Turk J Biol; 2020; 44(1):1-14. PubMed ID: 32123491
[TBL] [Abstract][Full Text] [Related]
2. Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas.
Schmitz R; Renné C; Rosenquist R; Tinguely M; Distler V; Menestrina F; Lestani M; Stankovic T; Austen B; Bräuninger A; Hansmann ML; Küppers R
Leukemia; 2005 Aug; 19(8):1452-8. PubMed ID: 15973455
[TBL] [Abstract][Full Text] [Related]
3. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
5. Indications of next-generation sequencing in non-Hodgkin's lymphoma.
Heimann P; Dewispelaere L
Curr Opin Oncol; 2020 Sep; 32(5):391-397. PubMed ID: 32675596
[TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma.
Wu XB; Hou SL; Zhang QH; Jia N; Hou M; Shui W
Front Oncol; 2022; 12():901547. PubMed ID: 35865478
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in B-cell non-Hodgkin's lymphoma.
Magić Z; Novković T; Cikota B; Tasić-Radić O; Tarabar O; Stamatović D
Vojnosanit Pregl; 2005 Feb; 62(2):87-96. PubMed ID: 15787160
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
9. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
10. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
11. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
13. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
Ma ES
Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
[TBL] [Abstract][Full Text] [Related]
14. Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA.
Sun P; Chen C; Xia Y; Wang Y; Liu PP; Bi XW; Shao YW; Ou QX; Wu X; Yang H; Nie M; Zhang XW; Li ZM; Jiang WQ
J Cancer; 2019; 10(2):323-331. PubMed ID: 30719126
[No Abstract] [Full Text] [Related]
15. Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B-cell lymphoma: Current state of the art and unmet clinical needs.
Ofori K; Bhagat G; Rai AJ
Br J Clin Pharmacol; 2021 Feb; 87(2):284-294. PubMed ID: 33080045
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphoma.
Smith MR
Curr Probl Cancer; 1996; 20(1):6-77. PubMed ID: 8919170
[TBL] [Abstract][Full Text] [Related]
17. Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Ma MCJ; Tadros S; Bouska A; Heavican T; Yang H; Deng Q; Moore D; Akhter A; Hartert K; Jain N; Showell J; Ghosh S; Street L; Davidson M; Carey C; Tobin J; Perumal D; Vose JM; Lunning MA; Sohani AR; Chen BJ; Buckley S; Nastoupil LJ; Davis RE; Westin JR; Fowler NH; Parekh S; Gandhi M; Neelapu S; Stewart D; Bhalla K; Iqbal J; Greiner T; Rodig SJ; Mansoor A; Green MR
Haematologica; 2022 Mar; 107(3):690-701. PubMed ID: 33792219
[TBL] [Abstract][Full Text] [Related]
18. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.
Mossafa H; Damotte D; Jenabian A; Delarue R; Vincenneau A; Amouroux I; Jeandel R; Khoury E; Martelli JM; Samson T; Tapia S; Flandrin G; Troussard X
Leuk Lymphoma; 2006 Sep; 47(9):1885-93. PubMed ID: 17065002
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin's Lymphoma.
Alfaifi A; Refai MY; Alsaadi M; Bahashwan S; Malhan H; Al-Kahiry W; Dammag E; Ageel A; Mahzary A; Albiheyri R; Almehdar H; Qadri I
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]